PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 189 filers reported holding PTC THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $218,960 | -20.6% | 7,527 | +11.0% | 0.00% | -50.0% |
Q2 2023 | $275,783 | -53.8% | 6,781 | -44.9% | 0.01% | -57.1% |
Q1 2023 | $596,635 | +129.7% | 12,317 | +81.0% | 0.01% | +100.0% |
Q4 2022 | $259,747 | -26.6% | 6,805 | -3.5% | 0.01% | -36.4% |
Q3 2022 | $354,000 | +34.1% | 7,055 | +6.9% | 0.01% | +37.5% |
Q2 2022 | $264,000 | +30.7% | 6,599 | +37.9% | 0.01% | -11.1% |
Q2 2021 | $202,000 | -11.0% | 4,785 | 0.0% | 0.01% | -10.0% |
Q1 2021 | $227,000 | -22.3% | 4,785 | -0.0% | 0.01% | 0.0% |
Q4 2020 | $292,000 | +22.2% | 4,786 | -6.5% | 0.01% | +25.0% |
Q3 2020 | $239,000 | -8.1% | 5,119 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $260,000 | +12.6% | 5,119 | -1.0% | 0.01% | +33.3% |
Q1 2020 | $231,000 | -6.5% | 5,170 | +0.7% | 0.01% | +20.0% |
Q4 2019 | $247,000 | +6.9% | 5,133 | 0.0% | 0.01% | +25.0% |
Q2 2019 | $231,000 | -39.2% | 5,133 | -53.7% | 0.00% | -33.3% |
Q4 2018 | $380,000 | -37.0% | 11,079 | -13.7% | 0.01% | -25.0% |
Q3 2018 | $603,000 | +47.1% | 12,840 | +5.7% | 0.01% | +33.3% |
Q2 2018 | $410,000 | +3.5% | 12,151 | -38.6% | 0.01% | 0.0% |
Q3 2017 | $396,000 | – | 19,796 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |